Executive Profile · Healthcare Analytics

Turning market intelligence into enterprise growth.

Executive and senior leader in Market Intelligence & Strategic Analytics with 27+ years guiding Fortune 500 and non-profit organizations through pricing, risk adjustment, M&A, and portfolio decisions worth billions.

27+Years of experience
$3B+Revenue informed
39Countries served
Portrait of Max Speight, Jr
Currently
Director, Market Intelligence & Strategic Analytics
AltaMed Health System

Leadership across Fortune 500 & mission-driven organizations

AltaMedOptumCenteneArjoWebMDEconovation
Scope & Scale

Outcomes measured in billions, not slides.

$3B+

Enterprise revenue informed by analytics delivered for Fortune 500 & non-profit clients

700K+

Covered lives served through consumer insight & retention programs

$376M

Cost structure reduction across enterprise portfolios

$220M

Net premium gain across 39 countries via validated M&A targets

Additional results include risk-adjusted premium improvement of $30M with the CMS Department of the Actuary and an MLR turnaround from 102% to 90% through cost structure improvement.

Executive Summary

A strategist, an operator, a partner to the C-suite.

Max has more than 27 years in healthcare spanning insurance, provider offices, FQHC plans, and medical device manufacturing. He has led the market and competitive analyses used in strategic positioning, benefit plan pricing, regulatory compliance, risk-adjustment modeling for Medicare, Medicaid, Commercial, and ACA lines, and value-based contracting with clinicians.

Across those years, he has designed and built Market Intelligence & Strategic Analytics capabilities , guiding them from strategic integration through tactical improvement , to deliver $33M revenue enhancement, 8% member retention on 700,000 lives, $2.6B risk-adjusted premium management, and $376M cost reduction.

His foundation is a rare blend: 7 years clinical (trauma medicine, radiology, orthopedics with the U.S. Navy & Marine Corps) and 20 years in strategy, economics, finance, actuarial science, and biostatistics. The combination produces decisions that hold up to both clinical and financial scrutiny.

Core Expertise

Eight enterprise domains, one integrated practice.

01

Strategic Planning & Growth

Aligning enterprise initiatives to capture market share, margin, and durable competitive advantage.

02

Risk Analysis & Modeling

Risk-adjusted premium capture and value-based contracting across Medicare, Medicaid, ACA, and Commercial lines.

03

Competitive Landscape

Market positioning, M&A target validation, and offensive/defensive strategy design.

04

Quality Systems

NCQA/HEDIS, STARs, CAHPS, JCI, and VBC program leadership across regulated environments.

05

Regulatory & Compliance

CMS, NIH, and Departments of Insurance reporting, filings, and audit-grade analytics.

06

Tools & Data Engineering

Oracle, MS Server, Tableau, PowerBI, SQL, R, STATA, SAS, SPSS , enterprise warehouse to insight.

07

Finance & Economics

HEOR, econometric modeling, MLR remediation, pricing, and PBM contract analytics.

08

Informatics & Governance

Data capture, governance, and operational implementation that turn information into outcomes.

Professional Experience

A 27-year arc through healthcare's most consequential decisions.

Sep 2023 – Mar 2026

AltaMed Health System

Director , Market Intelligence & Strategic Analytics
  • Led $3B enterprise market strategy analytics serving 700,000+ covered lives.
  • Engineered delivery-channel analysis across 3,100 clinicians and 70 hospitals; positioned #1 in California, #2 in the US.
  • Increased member retention 8% through episodic service enhancements in administrative and clinical areas.
  • Built the enterprise Strategic Market Landscape study guiding FY25–FY30 planning.
Jan 2020 – Mar 2026

Econovation Health Advisors, LLC

Owner , Market Analytics
  • Produced contract, economic, and risk-adjustment analyses for 1.1M consumers (Advantasure/UST).
  • Completed $80M HEOR studies bridging clinical, financial, and regulatory domains.
  • Implemented Agile reporting suites and informatics governance driving $22M cost improvement.
Oct 2016 – Jan 2020

Arjo

Senior Global Manager , International Economics & Marketing
  • Partnered with US, EU, and APAC C-suite on 9 product lines, 230 SKUs, across 29 countries.
  • Designed ROI models supporting $220M revenue streams and validated M&A growth to 16% share.
  • Engaged value-based contracting implementation for 56K clinicians worldwide.
Dec 2013 – Sep 2016

Centene Corporation

Director , Medicare, Medicaid, ACA Risk Adjustment
  • Designed risk adjustment applications unlocking $7B enterprise market value on 400K members.
  • Drove Medicare MLR from 102.7% → 90.6% across 9 states; implemented $33M cost savings.
  • Led Medicare Benefit Plan, Part D reconciliation, PBM contracting, and CMS filings.
Mar 2008 – Jul 2013

Optum , UnitedHealth Group

Director , Risk Models & Enterprise Product Analytics
  • Boosted annual CMS reimbursement capture by $30M+ through risk gap closure.
  • Authored informatics & data governance for 4M+ consumers across risk, contracting, and quality.
Mar 2003 – Nov 2007

WebMD

Product Manager , Business Intelligence & Data Science
  • Increased eHealth enrollment 40%+ with Chevron, Bank of America, and other Fortune 500 clients.
  • Designed consumer health assessment models and psychometric profiling for enterprise accounts.
Engagement Model

A 30/60/90/180-day pathway from intelligence to impact.

Phase 01
0–30days

Market Landscape

E/C/S officer needs assessment and current-state diagnostic.

Phase 02
60days

MISA Framework

Vision, concept, and operational SitRep signed off with leadership.

Phase 03
90days

Framework in Motion

Continuous implementation supporting 1/3/5-year strategic planning.

Phase 04
180days

Plans Delivered

FY27–30 plans finalized, external reporting and Rx industry review underway.

Endorsements

What senior leaders say about working with Max.

"
Max did some great work in support of our market intelligence, business intelligence and broader analytic work. He partnered with key stakeholders to understand their needs and executed delivery of both ad-hoc and production assets. Max built an effective team to deliver this enterprise analytic function.
Greg Townsend
SVP & Chief Data and Analytics Officer, AltaMed
"
Max is a skilled financial analyst. His analyses are always comprehensive and thorough. He cares about the integrity of the work and is always seeking innovative methodologies to further refine his analyses.
Joyce McCulloch
VP of Biostatistics, Optum
"
A strategic mindset paired with a sleeves-rolled-up approach. Max consistently translates complex information into decisions executive teams can act on.
Castulo de la Rocha
CEO & President, AltaMed
Education

Academic foundation.

  • University of Texas , San Antonio
    Executive M.A., Health Economics
    Dec 2027 · in progress
  • University of Oregon, Lundquist Graduate School of Business
    MBA, Finance & Marketing
    1994
  • University of Tennessee, College of Science
    B.S., Biology & Management Statistics
    1991
  • George Washington University
    A.S., Physics & Radiation Technology
    1991
  • Naval School of Health Sciences
    Hospital Corpsman / Pre-Medicine
    1986
Certifications & Service

Credentials and continuing development.

  • ARRT , American Registry of Radiological Technologists
  • Certified IT Project Management , Systemation
  • CORE Leadership , Kaiser Foundation
  • ASA , American Society of Actuaries (in progress)
  • CPM , Certification in Product Marketing (in progress)
U.S. Military Service
U.S. Navy , Fleet Marine Force Hospital Corpsman
Feb 1985 – Jun 1989

Navy & Marine Corps Medal · Air Warfare Specialist · Meritorious Honor · Cold War Medal · Navy Sea Service Deployment.

Let's Talk

Ready to align analytics with your enterprise strategy?

Whether you're navigating an M&A decision, a risk-adjustment program, or an FY planning cycle , let's explore where intelligence can move the number that matters.

Start the Conversation →